EN
HI
Summary
As of 26 Aug, 2026, Hester Biosciences stock price is ₹2395.1. During the trading session, the stock has moved between an intraday low of ₹2391.80 and an intraday high of ₹2433.70. Over the last 52 weeks, Hester Biosciences has traded between ₹1239.30 and ₹2683.60.
The stock has recorded a trading volume of 511 shares, with a market capitalization of ₹8506865. Its Average Traded Price (ATP) is ₹2413.10, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹2395.10.
Hester Biosciences has an upper circuit limit of ₹2906.10 and a lower circuit limit of ₹1937.50. The total value traded stands at ₹12.33 L, and the delivery percentage for the day is 49.64%.
The stock is currently traded with a market lot size of 1. Hester Biosciences also offers a dividend yield of 0.46%.
Hester Biosciences share price chart
Hester Biosciences Share Key Metrics
Volume
511.00
Market Cap
2060.19 CR
LTQ@LTP
1@2395.10
ATP
2413.1
Var Margin
21.91 %
Circuit Range
1937.5-2906.1
Delivery %
49.64 %
Value
12.33 L
ASM/GSM
No
Market Lot
1
Hester Biosciences Fundamentals
P/E Ratio
15.01
P/B Ratio
4.49
Div. Yield
0.46
Sector P/E
69.27
Sector P/B
3.36
Sec. Div. Yield
0.51
Hester Biosciences Resistance and Support
Pivot 2408.63
Resistance
First Resistance
2462.16
Second Resistance
2502.53
Third Resistance
2556.06
Support
First Support
2368.26
Second Support
2314.73
Third Support
2274.36
Hester Biosciences Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Wed Aug 26 2026 | 2421.8 | 2395.1 | -1.10% | 2433.7 | 2391.8 |
| Tue Aug 25 2026 | 2360 | 2421.8 | 2.42% | 2449 | 2355.1 |
| Mon Aug 24 2026 | 2351 | 2364.5 | -0.14% | 2383.5 | 2347 |
Hester Biosciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-30 | Quarterly Results |
| 2026-05-15 | Audited Results & Final Dividend |
| 2026-01-30 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-08-01 | Quarterly Results |
| 2025-05-09 | Audited Results & Final Dividend |
| 2025-01-30 | Quarterly Results |
| 2024-10-28 | Quarterly Results |
| 2024-08-02 | Quarterly Results |
Hester Biosciences News
Hester Biosciences Ltd - 524669 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Hester Biosciences announced a Postal Ballot to reclassify two promoters, Mr. Ravin Gandhi and Ms. Bela Gandhi, as public shareholders. This move, concerning their 4.74% and 4.71% stakes respectively, aims to comply with SEBI regulations and potentially enhance public float.
Aug 04 2026 19:23:18
Hester Biosciences Ltd - 524669 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Hester Biosciences held its Q1 FY27 earnings call, highlighting robust standalone performance with 14% revenue growth and 88% PAT increase. The company also announced a significant restructuring of a $12 million loan for its Hester Africa unit, making it interest-free.
Aug 01 2026 14:15:48
Read More
Hester Biosciences Management
| Name | Position |
|---|---|
| Bhupendra Gandhi | Chairman |
| Rajiv Gandhi | Managing Director & Chief Executive Officer |
Hester Biosciences Similar Stocks
Sai Parenteral's Ltd.
535.40
7.50 (1.42%)
Venus Remedies Ltd.
1629.00
-28.40 (1.71%)
Windlas Biotech Ltd.
987.20
-3.75 (0.38%)
Indoco Remedies Ltd.
223.31
-2.03 (0.90%)
Sakar Healthcare Ltd.
905.50
20.65 (2.33%)
Shukra Pharmaceuticals Ltd.
44.72
0.64 (1.45%)
Krsnaa Diagnostics Ltd.
562.00
-2.80 (0.50%)
NGL Fine-Chem Ltd.
2871.00
67.20 (2.40%)
Suraksha Diagnostic Ltd.
325.20
7.35 (2.31%)
Hester Biosciences FAQs
The Buying Price of Hester Biosciences share is 2395.1 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Hester Biosciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Hester Biosciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Hester Biosciences shares is 15.01. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Hester Biosciences shares is 4.49. Useful to assess the stock's value relative to its book value.
To assess Hester Biosciences’s valuation compare Sector P/E, P/B which are 69.27 & 3.36 with sector averages, along with growth rates and financial metrics.
The Market Cap of Hester Biosciences is 2060.19 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Hester Biosciences share price is 2683.60 & 1239.30. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Hester Biosciences belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
